New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis

被引：6
|
作者：
Droney, Luke [1 ,2 ]
Gillis, David [1 ,2 ,3 ]
Wong, Richard [1 ,2 ,4 ]
机构：
[1] Royal Brisbane & Womens Hosp, Pathol Queensland, Div Immunol, Herston, Qld, Australia
[2] Univ Queensland, Royal Brisbane & Womens Hosp, Fac Med, Brisbane, Qld, Australia
[3] Nambour Gen Hosp, Dept Immunol, Nambour, Australia
[4] Princess Alexandra Hosp, Dept Immunol, Woolloongabba, Qld, Australia
来源：
PATHOLOGY | 2017年 / 49卷 / 06期
关键词：
NECROTIZING MYOPATHY; STATIN; AUTOANTIBODIES;
D O I：
10.1016/j.pathol.2017.04.013
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：638 / 639
页数：2
相关论文
共 44 条
  • [31] Anti-inflammatory effects of hmg-coa reductase inhibitor (statin) on acute coronary arteritis in a rabbit model of Kawasaki disease
    Ozawa, S. I.
    Fujii, M.
    Yahata, T.
    Niboshi, A.
    Hamaoka, K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 102 - 102
  • [32] A-family anti-inflammatory cyclopentenone prostaglandins: A novel class of non-statin inhibitors of HMG-CoA reductase
    Paula Gutierrez, Lucila Ludmila
    Marques, Claudia Vieira
    Scomazzon, Sofia Pizzato
    Schroeder, Helena Trevisan
    Fernandes, Joao Roberto
    Rossato, Juliane da Silva
    Homem de Bittencourt Jr, Paulo Ivo
    BIOCHIMIE, 2021, 182 : 37 - 50
  • [33] Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis
    D. S. Gesto
    N. M. F. S. A. Cerqueira
    M. J. Ramos
    P. A. Fernandes
    Journal of Molecular Modeling, 2014, 20
  • [34] Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis
    Gesto, D. S.
    Cerqueira, N. M. F. S. A.
    Ramos, M. J.
    Fernandes, P. A.
    JOURNAL OF MOLECULAR MODELING, 2014, 20 (04)
  • [35] Novel anti-inflammatory effect of statins:: HMG-CoA reductase inhibitors reduce CD4+CD28null lymphocytes
    Brugaletta, S
    Liuzzo, G
    Trotta, G
    Zoccai, GB
    Aguzzi, G
    Piro, M
    Di Giannuario, G
    Biasucci, LM
    CIRCULATION, 2003, 108 (17) : 196 - 197
  • [36] Use of administrative databases may lead to incorrect estimates of the effects of nonaspirin nonsteroidal anti-inflammatory drugs on miyocardial infarction risk
    Kimmel, SE
    Berlin, JA
    Jaskowiak, J
    Kishel, L
    Strom, BL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 420A - 420A
  • [37] Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice
    Naito, Yuji
    Katada, Kazuhiro
    Takagi, Tomohisa
    Tsuboi, Hisato
    Isozaki, Yutaka
    Handa, Osamu
    Kokura, Satoshi
    Yoshida, Norimasa
    Ichikawa, Hiroshi
    Yoshikawa, Toshikazu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (06) : 997 - 1004
  • [38] Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules
    Das, Undurti N.
    LIPIDS IN HEALTH AND DISEASE, 2008, 7 (1)
  • [39] Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules
    Undurti N Das
    Lipids in Health and Disease, 7
  • [40] HMG-CoA reductase inhibitor pitavastatin elicits its anti-inflammatory effect through activation of BMK1/ERK5 in vascular endothelial cells
    Akaike, M
    Yagi, S
    Aihara, KI
    Ikeda, Y
    Iwase, T
    Hashizume, S
    Fujimura, M
    Azuma, H
    Matsumoto, T
    CIRCULATION, 2005, 112 (17) : U76 - U76
12345